Concepedia

Ming Zeng

MZ

Statistics

Publications

39

Citations

2.7K

H-Index

26

Active since

1995

Affiliations

National Institutes for Food and Drug Control(Current)

University of Electronic Science and Technology of China

Southwest University

Academy of Military Medical Sciences

Fujian Provincial Cancer Hospital

Ming Zeng is an author at National Institutes for Food and Drug Control specializing in medicine, microbiology, and natural sciences.

ORCID

Top concepts

Publications per year

1995–2023

39

Publications

39

Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study

Jing Huang, Jianming Xu, Yun Chen et al. · The Lancet Oncology · 2020 · 568 citations

, , +10

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial

Ming Zeng, Xuhu Mao, Jingxin Li et al. · The Lancet · 2015 · 292 citations

, , +4

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer

Xiaoshan Wang, Yifeng Bai, Vivek Verma et al. · JNCI Journal of the National Cancer Institute · 2022 · 231 citations · Full text

Functional Characterization of a Flavonoid Glycosyltransferase in Sweet Orange (Citrus sinensis)

Xiaogang Liu, Cailing Lin, Xiaodi Ma et al. · Frontiers in Plant Science · 2018 · 101 citations · Full text

Efficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer

Yongling Ji, Xianghui Du, Weiguo Zhu et al. · JAMA Oncology · 2021 · 101 citations · Full text

1–5 of 39